Xellar Biosystems is at the forefront of drug discovery, utilizing advanced technologies to create a more accurate representation of human biology through its innovative Preclinical Development Platform. This platform focuses on developing dynamic 3D tissue and organ models, which are essential for understanding complex biological interactions that traditional animal models often fail to capture. By employing proprietary high-throughput barrier-free 3D organ chip technology, Xellar enables the creation of tissue/organ chip disease models that facilitate the study of disease progression, drug responses, and therapeutic interventions in a physiologically relevant context. Their expertise in surface modification and extracellular matrix (ECM) hydrogel formulation allows for the replication of the intricate architecture and mechanical properties of human tissues, enhancing the precision of drug efficacy and safety assessments.

In addition to their organ-on-chip models, Xellar's platform incorporates advanced drug testing methodologies, including pharmacokinetics/pharmacodynamics (PK/PD) models and toxicity assessment models. These models utilize a variety of cell sourcing options, such as cell lines, primary cells, organoids, and induced pluripotent stem cells (iPSCs), to simulate specific disease conditions effectively. By integrating biology, engineering, and computational analysis, Xellar empowers researchers and pharmaceutical companies to advance their drug discovery efforts with greater accuracy and relevance, ultimately aiming to improve the success rates of clinical trials and expedite the identification of potential drug candidates.

United States

The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.

Xellar Biosystems

Company Details